Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Avidity Partners Management LP | 2,189,719 9.900% | 69,719 (+3.29%) | Filing History |
| 2023-02-14 06:15 am Purchase | 2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Bain Capital Life Sciences Fund II, L.P. | 2,124,694 11.000% | 2,124,694 (New Position) | Filing History |
| 2023-02-10 7:41 pm Purchase | 2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 1,463,829 7.200% | 1,113,829 (+318.24%) | Filing History |
| 2023-01-27 6:01 pm Purchase | 2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Ally Bridge MedAlpha Master Fund L.P. | 1,439,379 6.900% | 1,439,379 (New Position) | Filing History |
| 2023-01-25 5:00 pm Purchase | 2023-01-15 | 13G | Syros Pharmaceuticals, Inc. SYRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,253,828 6.040% | 1,253,828 (New Position) | Filing History |
| 2022-11-10 11:55 am Purchase | 2022-11-09 | 13G | Syros Pharmaceuticals, Inc. SYRS | FMR LLC | 104,614 0.516% | 104,614 (New Position) | Filing History |
| 2022-09-20 4:35 pm Purchase | 2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS | Avidity Partners Management LP | 2,120,000 9.900% | 2,120,000 (New Position) | Filing History |
| 2022-09-19 4:07 pm Purchase | 2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS | Deep Track Capital, LP | 699,281 9.990% | 699,281 (New Position) | Filing History |
| 2022-09-16 4:31 pm Sale | 2022-09-15 | 13D | Flexible Solutions International, Inc. FSI | TYME TECHNOLOGIES INC. TYME | 0 0.000% | -17,460,552 (Position Closed) | Filing History |
| 2022-07-13 5:15 pm Purchase | 2022-07-03 | 13D | Flexible Solutions International, Inc. FSI | TYME TECHNOLOGIES INC. TYME | 17,460,552 28.000% | 17,460,552 (New Position) | Filing History |
| 2022-07-13 5:10 pm Purchase | 2022-07-03 | 13D | Flexible Solutions International, Inc. FSI | Syros Pharmaceuticals Inc. SYRS | 17,819,723 9.900% | 17,819,723 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Syros Pharmaceuticals, Inc. SYRS | BlackRock Inc. BLK | 152,431 2.400% | -270,796 (-63.98%) | Filing History |
| 2022-04-11 09:01 am Sale | 2022-04-08 | 13G | Syros Pharmaceuticals, Inc. SYRS | FMR LLC | 579,788 9.298% | -353,492 (-37.88%) | Filing History |
| 2022-02-14 06:41 am Purchase | 2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Bain Capital Life Sciences Fund II, L.P. | 626,442 11.000% | 626,442 (New Position) | Filing History |
| 2022-02-14 06:06 am Sale | 2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Nikko Asset Management Americas, Inc. | 0 0.000% | -438,199 (Position Closed) | Filing History |
| 2022-02-11 4:17 pm Purchase | 2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Ally Bridge MedAlpha Master Fund L.P. | 393,052 6.300% | 89,740 (+29.59%) | Filing History |
| 2022-02-11 06:28 am Purchase | 2022-02-02 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 350,000 5.600% | 350,000 (New Position) | Filing History |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Syros Pharmaceuticals, Inc. SYRS | FMR LLC | 933,280 14.999% | 242,046 (+35.02%) | Filing History |
| 2022-02-04 06:09 am Sale | 2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Sumitomo Mitsui Trust Group, Inc. | 0 0.000% | -438,199 (Position Closed) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | BlackRock Inc. BLK | 423,227 6.800% | 90,671 (+27.26%) | Filing History |